NEW YORK (GenomeWeb News) — Promega has expanded its equity stake in Aussie RNAi company Benitec by buying 1.8 million ordinary shares at AU$.105 apiece ($.09), or $158,000, Benitec said today.
 
The deal, which is a 20-percent discount from the average trading price of Benitec shares over the past 60 days, follows the conversion of a year-old promissory note and increases Promega’s stake in the Australian company to 6.15 percent.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.